Xianxian Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xianxian Zhao has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Yang Luo
Kunming Medical University
6 shared publications Xiaoya Liu
Department of Oncology, Laboratory of Immunity, Inflammation & Cancer
4 shared publications- Weiling Fu
Department of Clinical Laboratory, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China
3 shared publications Ge Xu
Department of Orthopedics
2 shared publicationsGuangchao Qing
Center of Smart Laboratory and Molecular Medicine, Medical School , Chongqing University , Chongqing 400044 , China
2 shared publicationsHong Zhang
Central Laboratory, Chongqing University FuLing Hospital, Chongqing, 408099, China
2 shared publications
Latest Publications
- Open Access
- 3 February 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (2)
Three-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study
The long-term impact of left atrial appendage occlusion (LAAO) plus ablation for atrial fibrillation remains controversial. The present study aims to compare the three-year clinical outcomes of LAAO patients with or without one-staged ablation. The RECORD study (NCT03917563) was a prospective registry conducted in 39 participating sites in China between 1 April 2019 and 31 October 2020, which consecutively enrolled 3082 patients who successfully received the WATCHMAN LAAO device. The current study compared patients who received LAAO only to patients who underwent LAAO plus ablation. A 1:1 propensity score matching was performed to attenuate confounding. The primary outcome was a composite endpoint of cardiovascular death, stroke, and systemic embolism at 3-year. 1633/2928 (55.8%) patients received LAAO only and 1295/2928 (44.2%) received LAAO plus ablation. After propensity score matching, 1016/2032 (50.0%) were in the LAAO group and 1016/2032 (50.0%) in the LAAO plus ablation group. The mean ± SD age was 68.8 ± 9.3 years, with 815 (40.1%) participants being female. The mean ± SD CHA2DS2-VASc and HAS-BLED scores at baseline were 3.9 ± 1.8 and 2.4 ± 1.1, respectively. At three-year, compared to LAAO only, LAAO plus ablation was associated with a lower risk of cardiovascular death, stroke, systemic embolism (6.9%vs.10.4%, HRPSM:0.66, 95%CI: 0.49–0.89, P = 0.007), which was driven mainly by the lower risk of cardiovascular death (3.7% vs. 7.3%, HRPSM: 0.50, 95%CI: 0.34–0.74, P = 0.001). No significant between-group differences were noted for BARC-defined bleeding. LAAO plus ablation was associated with a lower risk of a composite of cardiovascular death, stroke, and systemic embolism than LAAO only at 3-year. However, given the observational nature of the current study, the results should be considered as hypothesis-generating only.
- 3 February 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (2)
Open AccessThree-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study
The long-term impact of left atrial appendage occlusion (LAAO) plus ablation for atrial fibrillation remains controversial. The present study aims to compare the three-year clinical outcomes of LAAO patients with or without one-staged ablation. The RECORD study (NCT03917563) was a prospective registry conducted in 39 participating sites in China between 1 April 2019 and 31 October 2020, which consecutively enrolled 3082 patients who successfully received the WATCHMAN LAAO device. The current study compared patients who received LAAO only to patients who underwent LAAO plus ablation. A 1:1 propensity score matching was performed to attenuate confounding. The primary outcome was a composite endpoint of cardiovascular death, stroke, and systemic embolism at 3-year. 1633/2928 (55.8%) patients received LAAO only and 1295/2928 (44.2%) received LAAO plus ablation. After propensity score matching, 1016/2032 (50.0%) were in the LAAO group and 1016/2032 (50.0%) in the LAAO plus ablation group. The mean ± SD age was 68.8 ± 9.3 years, with 815 (40.1%) participants being female. The mean ± SD CHA2DS2-VASc and HAS-BLED scores at baseline were 3.9 ± 1.8 and 2.4 ± 1.1, respectively. At three-year, compared to LAAO only, LAAO plus ablation was associated with a lower risk of cardiovascular death, stroke, systemic embolism (6.9%vs.10.4%, HRPSM:0.66, 95%CI: 0.49–0.89, P = 0.007), which was driven mainly by the lower risk of cardiovascular death (3.7% vs. 7.3%, HRPSM: 0.50, 95%CI: 0.34–0.74, P = 0.001). No significant between-group differences were noted for BARC-defined bleeding. LAAO plus ablation was associated with a lower risk of a composite of cardiovascular death, stroke, and systemic embolism than LAAO only at 3-year. However, given the observational nature of the current study, the results should be considered as hypothesis-generating only.
- 15 April 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (16) , 9000-9007
A Versatile Colorimetric Diagnostic Platform Based on Primer Exchange Reaction Cascades Driven Loop-Mediated Isothermal Amplification
The primer exchange reaction (PER), as a well-established and sophisticated isothermal nucleic acid amplification strategy, has been extensively employed to amplify various genetic biomarkers. However, the amplification efficiency of conventional PER is generally unsatisfactory due to its linear signal-amplifying mechanism. In this study, we developed a versatile colorimetric platform by rationally integrating Primer exchange reaction with efficient Loop-mediated isothermal amplification (LAMP), termed vcPeLa, for the rapid and sensitive detection of cancer-related biomarkers, such as microRNAs (miRNAs) and carcinoembryonic antigen (CEA). The PER cascade in the vcPeLa can be directly initiated by the target, resulting in the production of long single-stranded DNA products with repeated functional sections. These repeats in the product can serve as the template to produce a significant number of double stem-loop DNAs with the cooperation of DNA polymerase and hairpin structure primer probes. These DNAs are the primary starting materials for subsequent LAMP. A substantial quantity of pyrophosphate can be recognized by Cu2+-chelated pp Probe (pyrophosphate sensing probe). The Cu2+ is removed from the Cu2+-chelated pp Probe as a result of the formation of a complex between Cu2+ and pyrophosphate, which results in color changes. Consequently, the vcPeLa platform is feasible to detect 0.31 fM miRNA and 0.043 ng/mL CEA with high selectivity and stability without the requirement of introducing any additional reaction steps or sample transfer operations in comparison to conventional assays. Therefore, this facile and ultrasensitive vcPeLa platform provides a new promising tool for cancer diagnosis and biomarker screening.
- 15 April 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (16) , 9000-9007
A Versatile Colorimetric Diagnostic Platform Based on Primer Exchange Reaction Cascades Driven Loop-Mediated Isothermal Amplification
The primer exchange reaction (PER), as a well-established and sophisticated isothermal nucleic acid amplification strategy, has been extensively employed to amplify various genetic biomarkers. However, the amplification efficiency of conventional PER is generally unsatisfactory due to its linear signal-amplifying mechanism. In this study, we developed a versatile colorimetric platform by rationally integrating Primer exchange reaction with efficient Loop-mediated isothermal amplification (LAMP), termed vcPeLa, for the rapid and sensitive detection of cancer-related biomarkers, such as microRNAs (miRNAs) and carcinoembryonic antigen (CEA). The PER cascade in the vcPeLa can be directly initiated by the target, resulting in the production of long single-stranded DNA products with repeated functional sections. These repeats in the product can serve as the template to produce a significant number of double stem-loop DNAs with the cooperation of DNA polymerase and hairpin structure primer probes. These DNAs are the primary starting materials for subsequent LAMP. A substantial quantity of pyrophosphate can be recognized by Cu2+-chelated pp Probe (pyrophosphate sensing probe). The Cu2+ is removed from the Cu2+-chelated pp Probe as a result of the formation of a complex between Cu2+ and pyrophosphate, which results in color changes. Consequently, the vcPeLa platform is feasible to detect 0.31 fM miRNA and 0.043 ng/mL CEA with high selectivity and stability without the requirement of introducing any additional reaction steps or sample transfer operations in comparison to conventional assays. Therefore, this facile and ultrasensitive vcPeLa platform provides a new promising tool for cancer diagnosis and biomarker screening.
- Open Access
- 4 December 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (50) , 49081-49087
Rolling Circle Amplification Integrating with Exonuclease-III-Assisted Color Reaction for Sensitive Telomerase Activity Analysis
Telomerase activation can lead to the escape from cell senescence and immortalization, playing a crucial role in the growth and proliferation of cancer cells. Therefore, the detection of telomerase activity is essential for cancer diagnosis and treatment. Herein, we develop a novel ultrasensitive and visually detectable platform. By incorporation of exonuclease-III (Exo-III), this platform achieves dual signal amplification of rolling circle amplification products. Additionally, the colorimetric analysis of 3,3',5,5'-tetramethylbiphenyl (TMB) chromogenic reaction system provides this approach with unique advantages such as simplicity, speediness, and sensitivity. The detection platform exhibits high sensitivity and specificity in actual sample testing, which aligns closely with results obtained using commercial kits. Moreover, it offers ease-of-use through visual determination by the naked eyes. This finding indicates that our proposed sensing method performs satisfactorily in detecting telomerase in real biological samples. Henceforth, we believe that this sensing platform holds great potential for clinical diagnosis and anticancer drug development.
- 4 December 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (50) , 49081-49087
Open AccessRolling Circle Amplification Integrating with Exonuclease-III-Assisted Color Reaction for Sensitive Telomerase Activity Analysis
Telomerase activation can lead to the escape from cell senescence and immortalization, playing a crucial role in the growth and proliferation of cancer cells. Therefore, the detection of telomerase activity is essential for cancer diagnosis and treatment. Herein, we develop a novel ultrasensitive and visually detectable platform. By incorporation of exonuclease-III (Exo-III), this platform achieves dual signal amplification of rolling circle amplification products. Additionally, the colorimetric analysis of 3,3',5,5'-tetramethylbiphenyl (TMB) chromogenic reaction system provides this approach with unique advantages such as simplicity, speediness, and sensitivity. The detection platform exhibits high sensitivity and specificity in actual sample testing, which aligns closely with results obtained using commercial kits. Moreover, it offers ease-of-use through visual determination by the naked eyes. This finding indicates that our proposed sensing method performs satisfactorily in detecting telomerase in real biological samples. Henceforth, we believe that this sensing platform holds great potential for clinical diagnosis and anticancer drug development.
- 21 November 2024
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 150 (1) , 46-54
Reliable and precise lipoprotein detection based on a self-priming hairpin-triggered Cas12a/crRNA based signaling strategy
Cardiovascular disease, intimately linked to dyslipidemia, is one of the leading global causes of mortality. Dyslipidaemia often presents as an elevated concentration of low-density lipoprotein (LDL) and a decreased concentration of high-density lipoprotein (HDL). Therefore, accurately measuring the levels of LDL and HDL particles is crucial for assessing the risk of developing cardiovascular diseases. However, conventional approaches can commonly quantify HDL/LDL particles by detecting cholesterol or protein molecules within them, which may fail to reflect the number of intact particles. In addition, these approaches are sometimes tedious and time-consuming, highlighting the need for a novel method for precise and effective identification of intact HDL and LDL particles. We have devised a technique that allows accurately and sensitively determining the levels of intact HDL and LDL in a sample without the need for isolation. This method relies on antibody-based immobilization and a self-priming hairpin-triggered Cas12a/crRNA signaling strategy. Based on the elegant design, this technique can be employed to directly and precisely measure the concentration of “actual” HDL and LDL particles, rather than the cholesterol content inside HDL and LDL. The approach has detection limits of 12.3 mg dL−1 and 5.4 mg dL−1 for HDL and LDL, respectively, and is also suitable for analyzing lipoproteins in clinical samples. Hence, this platform exhibits immense potential for clinical applications and health management.
- 21 November 2024
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 150 (1) , 46-54
Reliable and precise lipoprotein detection based on a self-priming hairpin-triggered Cas12a/crRNA based signaling strategy
Cardiovascular disease, intimately linked to dyslipidemia, is one of the leading global causes of mortality. Dyslipidaemia often presents as an elevated concentration of low-density lipoprotein (LDL) and a decreased concentration of high-density lipoprotein (HDL). Therefore, accurately measuring the levels of LDL and HDL particles is crucial for assessing the risk of developing cardiovascular diseases. However, conventional approaches can commonly quantify HDL/LDL particles by detecting cholesterol or protein molecules within them, which may fail to reflect the number of intact particles. In addition, these approaches are sometimes tedious and time-consuming, highlighting the need for a novel method for precise and effective identification of intact HDL and LDL particles. We have devised a technique that allows accurately and sensitively determining the levels of intact HDL and LDL in a sample without the need for isolation. This method relies on antibody-based immobilization and a self-priming hairpin-triggered Cas12a/crRNA signaling strategy. Based on the elegant design, this technique can be employed to directly and precisely measure the concentration of “actual” HDL and LDL particles, rather than the cholesterol content inside HDL and LDL. The approach has detection limits of 12.3 mg dL−1 and 5.4 mg dL−1 for HDL and LDL, respectively, and is also suitable for analyzing lipoproteins in clinical samples. Hence, this platform exhibits immense potential for clinical applications and health management.
- 8 November 2024
- Published by Elsevier in Analytical Biochemistry
- Vol. 697, 115716
A simple and enzyme-free method for sensitive p53 analysis based on DNAzyme-mediated signal amplification
- 8 November 2024
- Published by Elsevier in Analytical Biochemistry
- Vol. 697, 115716
A simple and enzyme-free method for sensitive p53 analysis based on DNAzyme-mediated signal amplification
- 23 July 2024
- Published by Elsevier in Computers and Electrical Engineering
- Vol. 119, 109503
Enhancing sustainability in electric mobility: Exploring blockchain applications for secure EV charging and energy management
- 23 July 2024
- Published by Elsevier in Computers and Electrical Engineering
- Vol. 119, 109503
Enhancing sustainability in electric mobility: Exploring blockchain applications for secure EV charging and energy management
- Open Access
- 21 March 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (13) , 15350-15356
Label-Free, Sensitive, and Versatile Colorimetric Method for Molecule Detection via the G-Quadruplex-Based Signal Quenching Strategy
Signal amplification strategies have emerged as a prominent tool in the field of improving the detection sensitivity of small extracellular vesicles (sEVs). It is important to highlight that the utilization of signal quenching strategies is not commonly implemented. A detection technique for sEVs was established based on the unwinding of G-quadruplex using Klenow fragment polymerase (KF), which served as an inspiration for this study. This system is characterized by its simplicity and lack of labeling, making it an efficient approach for signal quenching. In the presence of sEVs, the CD63 aptamer in the capture@sMBs complex binds with the CD63 protein on the surface of sEVs to release trigger sequences, which were employed as a primer to mediate the DNA polymerase/endonuclease-assisted signal recycling. The signal recycling process produces numerous single-stranded DNA sequences that can bind to the toehold section of the G-quadruplex. This leads to the rupture of the G-quadruplex structure and the subsequent deactivation of a DNAzyme generated by the G-quadruplex structure and hemin, thereby inhibiting its biological catalytic function. Consequently, the G-quadruplex structure would undergo a transformation to a duplex structure, leading to the emergence of a discernible differential signal that can be noticed in a majority of instances, even without the aid of magnification devices. The decrease in the prominent signal allows for the efficient analysis of target sEVs, which exhibit a notably low detection limit. In addition to the detection of sEVs, the approach has also been utilized for the investigation of miRNA-21. The approach demonstrates a high level of selectivity and robustness in its capacity to differentiate between target miRNA and base-mismatched miRNA as well as other miRNA families. This statement suggests that the assay holds significant promise for use in biochemical research and clinical diagnosis.
- 21 March 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (13) , 15350-15356
Open AccessLabel-Free, Sensitive, and Versatile Colorimetric Method for Molecule Detection via the G-Quadruplex-Based Signal Quenching Strategy
Signal amplification strategies have emerged as a prominent tool in the field of improving the detection sensitivity of small extracellular vesicles (sEVs). It is important to highlight that the utilization of signal quenching strategies is not commonly implemented. A detection technique for sEVs was established based on the unwinding of G-quadruplex using Klenow fragment polymerase (KF), which served as an inspiration for this study. This system is characterized by its simplicity and lack of labeling, making it an efficient approach for signal quenching. In the presence of sEVs, the CD63 aptamer in the capture@sMBs complex binds with the CD63 protein on the surface of sEVs to release trigger sequences, which were employed as a primer to mediate the DNA polymerase/endonuclease-assisted signal recycling. The signal recycling process produces numerous single-stranded DNA sequences that can bind to the toehold section of the G-quadruplex. This leads to the rupture of the G-quadruplex structure and the subsequent deactivation of a DNAzyme generated by the G-quadruplex structure and hemin, thereby inhibiting its biological catalytic function. Consequently, the G-quadruplex structure would undergo a transformation to a duplex structure, leading to the emergence of a discernible differential signal that can be noticed in a majority of instances, even without the aid of magnification devices. The decrease in the prominent signal allows for the efficient analysis of target sEVs, which exhibit a notably low detection limit. In addition to the detection of sEVs, the approach has also been utilized for the investigation of miRNA-21. The approach demonstrates a high level of selectivity and robustness in its capacity to differentiate between target miRNA and base-mismatched miRNA as well as other miRNA families. This statement suggests that the assay holds significant promise for use in biochemical research and clinical diagnosis.
- 18 January 2022
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 94 (4) , 2298-2304
A Versatile Platform for Sensitive and Label-Free Identification of Biomarkers through an Exo-III-Assisted Cascade Signal Amplification Strategy
The development of a versatile and sensitive analytical biomarker detection platform is important for both early diagnosis and treatment of diseases. In the present study, we propose a novel fluorescence-based, ultrasensitive, and label-free biomarker detection platform. This platform relies on a flexible probe design compatible for multiple biomarker identification and Exo-III enzyme-triggered cascade signal amplification. We have validated that this label-free platform exhibits high sensitivity and specificity. Indeed, this platform exhibited brilliant analytical performance in qualifying a carcinoembryonic antigen and small extracellular vesicles (sEVs). It also shows excellent capability in multiplexing mapping of surface proteins of various cancer-derived sEVs. Therefore, we believe that the proposed sensing platform has great potential for clinical diagnosis and anticancer drug development.
- 18 January 2022
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 94 (4) , 2298-2304
A Versatile Platform for Sensitive and Label-Free Identification of Biomarkers through an Exo-III-Assisted Cascade Signal Amplification Strategy
The development of a versatile and sensitive analytical biomarker detection platform is important for both early diagnosis and treatment of diseases. In the present study, we propose a novel fluorescence-based, ultrasensitive, and label-free biomarker detection platform. This platform relies on a flexible probe design compatible for multiple biomarker identification and Exo-III enzyme-triggered cascade signal amplification. We have validated that this label-free platform exhibits high sensitivity and specificity. Indeed, this platform exhibited brilliant analytical performance in qualifying a carcinoembryonic antigen and small extracellular vesicles (sEVs). It also shows excellent capability in multiplexing mapping of surface proteins of various cancer-derived sEVs. Therefore, we believe that the proposed sensing platform has great potential for clinical diagnosis and anticancer drug development.
- 1 November 2020
- Published by Elsevier in Microchemical Journal
- Vol. 158
CRISPR-Cas12a enhanced rolling circle amplification method for ultrasensitive miRNA detection
- 1 November 2020
- Published by Elsevier in Microchemical Journal
- Vol. 158
CRISPR-Cas12a enhanced rolling circle amplification method for ultrasensitive miRNA detection
- 15 July 2020
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (32) , 35958-35966
Spatiotemporally Controllable MicroRNA Imaging in Living Cells via a Near-Infrared Light-Activated Nanoprobe
In situ spatiotemporal microRNAs (miRNAs) imaging in mammal cells plays an essential role in illustrating its structures and biological functions. Herein, we proposed a near-infrared light (NIR)-activated nanoprobe for high-sensitive in situ controllable miRNA imaging in living cells. The NIR-activated nanoprobe employed an upconversion nanoparticle that acted as a NIR-to-UV transducer to trigger the following photocleavage toward a dumbbell DNA probe tethered on the surface of nanoparticle. The structure change of the dumbbell probe then induced a catalytic hairpin assembly of target miRNAs, by which in situ readout of the amplified fluorescence signal were enabled. Additionally, both intracellular miRNA imaging and accurate quantification in live cells were realized without damaging the cell membranes. Compared with conventional in situ strategies, the proposed approach remarkedly increases imaging efficiency by eliminating those unfavored intercellular molecular imaging background. We assured that the proposed NIR-activated miRNA sensing strategy will add to the advancement for bioanalysis in living systems, which is of crucial importance in the diagnosis of various human diseases, especially cancers.
- 15 July 2020
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (32) , 35958-35966
Spatiotemporally Controllable MicroRNA Imaging in Living Cells via a Near-Infrared Light-Activated Nanoprobe
In situ spatiotemporal microRNAs (miRNAs) imaging in mammal cells plays an essential role in illustrating its structures and biological functions. Herein, we proposed a near-infrared light (NIR)-activated nanoprobe for high-sensitive in situ controllable miRNA imaging in living cells. The NIR-activated nanoprobe employed an upconversion nanoparticle that acted as a NIR-to-UV transducer to trigger the following photocleavage toward a dumbbell DNA probe tethered on the surface of nanoparticle. The structure change of the dumbbell probe then induced a catalytic hairpin assembly of target miRNAs, by which in situ readout of the amplified fluorescence signal were enabled. Additionally, both intracellular miRNA imaging and accurate quantification in live cells were realized without damaging the cell membranes. Compared with conventional in situ strategies, the proposed approach remarkedly increases imaging efficiency by eliminating those unfavored intercellular molecular imaging background. We assured that the proposed NIR-activated miRNA sensing strategy will add to the advancement for bioanalysis in living systems, which is of crucial importance in the diagnosis of various human diseases, especially cancers.